E. Hennig

发表

FISH for BCR-ABL on interphases of peripheral blood neutrophils but not of unselected white cells correlates with bone marrow cytogenetics in CML patients treated with imatinib

U. Reinhold, D. Niederwieser, M. Deininger, 2003, Leukemia.

Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions.

A. Green, R. Clark, G. Vassiliou, 2003, Blood.

polyclonal hematopoiesis in the majority patients in cytogenetic remission to imatinib but restoration of cells in some CML - Emergence of clonal cytogenetic abnormalities in Ph

K. Krohn, M. Deininger, H. Al-Ali, 2012 .

Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority.

K. Krohn, M. Deininger, D. Niederwieser, 2003, Blood.

Does the P 2 X 1 del variant lacking 17 amino acids in its extracellular domain represent a relevant functional ion channel in platelets ?

L. Campbell, A. Green, D. Niederwieser, 2002 .

No evidence for persistence of BCR-ABL–positive cells in patients in molecular remission after conventional allogeneic transplantation for chronic myeloid leukemia

M. Deininger, D. Niederwieser, R. Krahl, 2000 .

No evidence for persistence of BCR-ABL-positive cells in patients in molecular remission after conventional allogenic transplantation for chronic myeloid leukemia.

D. Niederwieser, A. Chase, R. Krahl, 2000, Blood.

The BCR/ABL-extra signal fluorescence in situ hybridization system reliably detects deletions upstream of the ABL locus: implications for reporting of results and followup of chronic myelogenous leukemia patients.

D. Niederwieser, R. Krahl, Christel Müller, 2002, Cancer genetics and cytogenetics.

CML with an e1a3 BCR-ABL fusion: rare, benign, and a potential diagnostic pitfall.

D. Niederwieser, E. Hennig, S. Leiblein, 2002, Blood.

Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma

G. Behre, D. Niederwieser, T. Lindner, 2014, Journal of Cancer Research and Clinical Oncology.

Deletions of the derivative chromosome 9 do not account for the poor prognosis associated with Philadelphia-positive acute lymphoblastic leukemia.

L. Campbell, A. Green, D. Niederwieser, 2002, Blood.

Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority.

K. Krohn, M. Deininger, D. Niederwieser, 2003, Blood.